EI
TXG icon

Ellevest Inc’s 10x Genomics TXG Stock Holding History

Ellevest Inc’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-305
Closed -$17K – 1536
2023
Q1 		$17K Buy
305
+121
+66% +$5.65K ﹤0.01% 885
2022
Q4 		$6.71K Buy
184
+101
+122% +$3.3K ﹤0.01% 1121
2022
Q3 		$2K Buy
+83
New +$3.16K ﹤0.01% 1382
2022
Q2 		– Sell
-60
Closed -$5K – 1691
2022
Q1 		$5K Sell
60
-77
-56% -$6.74K ﹤0.01% 1054
2021
Q4 		$20K Buy
137
+13
+10% +$1.99K ﹤0.01% 724
2021
Q3 		$18K Hold
124
– – ﹤0.01% 696
2021
Q2 		$24K Buy
124
+24
+24% +$4.34K ﹤0.01% 608
2021
Q1 		$18K Hold
100
– – ﹤0.01% 680
2020
Q4 		$14K Hold
100
– – ﹤0.01% 690
2020
Q3 		$12K Hold
100
– – ﹤0.01% 622
2020
Q2 		$9K Buy
+100
New +$7.79K ﹤0.01% 647

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Ellevest Inc's TXG Position: Q2 2023 in Review

Ellevest Inc sold out of 10x Genomics (TXG) in Q2 2023, closing a stake of 305 shares — an estimated $17K sold.

Ellevest Inc first reported a position in TXG in Q2 2020 and held it in 11 quarters. The position peaked at $24K in Q2 2021. 274 funds tracked by Wall St. Rank hold TXG as of Q2 2023.

  • Ellevest Inc reported no remaining 10x Genomics position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 305 10x Genomics shares in Q2 2023, an estimated $17K.
  • Ellevest Inc first reported a position in 10x Genomics in Q2 2020 and held it in 11 quarters.
  • Ellevest Inc's 10x Genomics position peaked at $24K in Q2 2021.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.